eMedicine Specialties > Neurology > Neuro-otology

Inner Ear, Labyrinthitis

Author: Mark E Boston, MD, Chairman, Department of Otolaryngology-Head and Neck Surgery, Wilford Hall Medical Center, Lackland Air Force Base
Coauthor(s): Barry Strasnick, MD, FACS, Chairman, Professor, Department of Otolaryngology - Head and Neck Surgery, Eastern Virginia Medical School; Amalia Renee Steinberg, MD, Resident Physician, Department of Otolaryngology, Eastern Virginia Medical School
Contributor Information and Disclosures

Updated: Jan 14, 2010

Introduction

Background

Labyrinthitis is an inflammatory disorder of the inner ear or labyrinth. Clinically, this condition produces disturbances of balance and hearing to varying degrees and may affect one or both ears. Bacteria or viruses can cause acute inflammation of the labyrinth in conjunction with either local or systemic infections. Autoimmune processes may also cause labyrinthitis. Vascular ischemia may result in acute labyrinthine dysfunction that mimics labyrinthitis. 

Pathophysiology

The anatomic relationships of the labyrinth, middle ear, mastoid, and subarachnoid space are essential to understanding the pathophysiology of labyrinthitis. The labyrinth is composed of an outer osseous framework surrounding a delicate membranous network that contains the peripheral sensory organs for balance and hearing. (See Media file 1.) 

Anatomy of the labyrinth.

Anatomy of the labyrinth.

Anatomy of the labyrinth.

Anatomy of the labyrinth.



These sensory organs include the utricle, saccule, semicircular canals, and cochlea. Symptoms of labyrinthitis occur when infectious microorganisms or inflammatory mediators invade the membranous labyrinth and damage the vestibular and auditory end organs.

The labyrinth lies within the petrous portion of the temporal bone adjacent to the mastoid cavity and connects with the middle ear at the oval and round windows. The labyrinth maintains connections with the central nervous system and subarachnoid space by way of the internal auditory canal and cochlear aqueduct. Bacteria may gain access to the membranous labyrinth by these pathways or through congenital or acquired defects of the bony labyrinth. Viruses may spread to labyrinthine structures hematogenously or by way of the aforementioned preformed pathways.

Viral and bacterial labyrinthitis are sufficiently different to warrant discussing them as separate disease processes.

Viral labyrinthitis

Viral labyrinthitis is characterized by a sudden, unilateral loss of vestibular function and hearing. The acute onset of severe, often incapacitating, vertigo, frequently associated with nausea and vomiting, is characteristic of this disorder. The patient is often bedridden while the symptoms gradually subside. Vertigo eventually resolves after several days to weeks; however, unsteadiness and positional vertigo may persist for several months. Hearing loss is common and may be the primary presenting symptom in many patients. Physical examination findings include spontaneous nystagmus towards the unaffected side with diminished or absent caloric responses in the affected ear. The hearing loss is usually mild to moderate and typically evident in the higher frequencies (>2000 Hz), although any degree or type of hearing loss may be present.

An upper respiratory tract infection precedes the onset of cochleovestibular symptoms in up to 50% of cases. Recurrent attacks are reported but are rare and may be confused with Ménière disease. Resolution of vertigo and dysequilibrium is common and is due to partial recovery of vestibular function with concurrent central compensation of the remaining unilateral vestibular deficit. Return of hearing usually mirrors the return of vestibular function.

Viral labyrinthitis is often confused with vestibular neuritis, and the terms are occasionally used interchangeably in the literature. However, most authors agree that vestibular neuritis is a disorder of the vestibular nerve and is not associated with hearing loss.1 Because the cochlea is affected in pan-labyrinthine inflammation, hearing loss is always present in persons with viral labyrinthitis.

Vestibular neuritis typically manifests as sudden acute vertigo without hearing loss in an otherwise healthy patient. The condition is more common in the fourth and fifth decades of life and affects men and women equally. An upper respiratory tract infection often precedes the condition, and the disorder is more common in the spring and early summer. Histopathological nerve studies of patients with vestibular neuritis demonstrate axonal loss, endoneurial fibrosis, and atrophy.1 These findings are consistent with a viral inflammatory etiology. The treatment of vestibular neuritis and viral labyrinthitis is similar.

A unique form of viral labyrinthitis is herpes zoster oticus, or Ramsay-Hunt syndrome. The cause of this disorder is reactivation of a latent varicella-zoster virus infection occurring years after the primary infection. Evidence suggests that the virus may attack the spiral and vestibular ganglion in addition to the cochlear and vestibular nerves.2 The initial symptoms are deep, burning, auricular pain followed a few days later by the eruption of a vesicular rash in the external auditory canal and concha. Vertigo, hearing loss, and facial weakness may follow singly or collectively. Symptoms typically improve over a few weeks; however, patients often suffer permanent hearing loss and persistent reduction of caloric responses.3

Viral infections can cause both congenital and acquired hearing loss. Rubella and cytomegalovirus are the best-recognized viral causes of prenatal hearing loss. Virally induced hearing loss in the postnatal period is usually due to mumps or measles. Viral infections are also implicated in idiopathic sudden sensorineural hearing loss (SNHL). Experimental evidence suggests that inflammatory proteins play a critical role in the pathogenesis of cytomegalovirus-induced hearing loss.4  More specific information regarding these viral diseases are covered in other articles. (See eMedicine Pediatric articles Measles, Mumps, Cytomegalovirus Infection, and Rubella.)

Bacterial labyrinthitis

Bacterial labyrinthitis is a potential consequence of meningitis or otitis media and may occur by either direct bacterial invasion (suppurative labyrinthitis) or through the passage of bacterial toxins and other inflammatory mediators into the inner ear (serous labyrinthitis). Meningitis typically affects both ears, whereas otogenic infections typically cause unilateral symptoms. Bacteria can spread from the cerebrospinal fluid to the membranous labyrinth by way of the internal auditory canal or cochlear aqueduct.

Bacterial infections of the middle ear or mastoid most commonly spread to the labyrinth through a dehiscent horizontal semicircular canal.5 Usually, the dehiscence is the result of erosion by a cholesteatoma. Suppurative labyrinthitis resulting from otitis media is uncommon in the postantibiotic era. When suppurative labyrinthitis occurs, it is almost always associated with cholesteatoma. Profound hearing loss, severe vertigo, ataxia, and nausea and vomiting are common symptoms of bacterial labyrinthitis.

Treatment of suppurative labyrinthitis is aimed at eradicating the underlying infection, providing supportive care to the patient, draining middle ear effusions or mastoid infections, and preventing the spread of infection. Labyrinthitis ossificans often follows suppurative labyrinthitis; therefore, decisions regarding cochlear implantation must be made early. Meningitis also may result in progressive hearing loss secondary to necrosis and fibrosis of the membranous cochlea and labyrinth.6

Serous labyrinthitis occurs when bacterial toxins and host inflammatory mediators, such as cytokines, enzymes, and complement, cross the round window membrane, causing inflammation of the labyrinth in the absence of direct bacterial contamination.7 This condition is associated with acute or chronic middle ear disease and is believed to be one of the most common complications of otitis media.

Toxins, enzymes, and other inflammatory products infiltrate the scala tympani, forming a fine precipitate just medial to the round window membrane. Penetration of the inflammatory agents into the endolymph at the basilar turn of the cochlea results in a mild-to-moderate high-frequency SNHL. Audiography testing reveals a mixed hearing loss when a middle ear effusion is present. Vestibular symptoms may occur but are less common. Treatment is aimed at eliminating the underlying infection and clearing the middle ear space of effusion. The hearing loss is usually transient but may persist if the otitis is left untreated.

Autoimmune labyrinthitis is an uncommon cause of sensorineural hearing loss and may occur as a local, inner ear process or as part of a systemic autoimmune disease such as Wegener granulomatosis or polyarteritis nodosa. Hearing loss in autoimmune inner ear disease is typically bilateral and progressive over weeks to months and vestibular complaints may occur in up to 80% of patients with autoimmune inner ear disease.8,9 Currently, no accurate or reliable autoimmune test is commercially available and the diagnosis of autoimmune labyrinthitis rests on a positive clinical response to steroid therapy.10  

Frequency

United States

Although definitive epidemiological data are lacking, viral labyrinthitis is the most common form of labyrinthitis observed in clinical practice. The prevalence of sudden SNHL is estimated at 1 case in 10,000 persons, with up to 40% of these patients complaining of vertigo or dysequilibrium.11 One study reported that 37 of 240 patients presenting with positional vertigo had viral labyrinthitis.12  Auditory and vestibular symptoms develop in approximately 25% of patients with herpes oticus, in addition to the facial paralysis and vesicular rash that characterize the disease.3 Bacterial labyrinthitis is rare in the postantibiotic era, although bacterial meningitis remains a significant cause of hearing loss. Auditory symptoms, vestibular symptoms, or both may be present in as many as 20% of children with meningitis.13

Mortality/Morbidity

Deaths associated with labyrinthitis are not reported except in cases of meningitis or overwhelming sepsis. The morbidity of labyrinthitis, especially bacterial labyrinthitis, is significant.

  • Bacterial labyrinthitis, regardless of etiology, accounts for one third of all cases of acquired hearing loss. 
  • In the pediatric population, the risk of hearing loss secondary to meningitis is estimated to be 10-20%.14,13  
  • One study reported dizziness following pneumococcal meningitis in 23% of patients.15  
  • S treptococcus pneumoniae appears to be the causative agent, most likely associated with meningitis-associated hearing loss.16  
  • Ménière disease may follow an episode of suppurative or serous labyrinthitis and is most likely due to fibrosis of the endolymphatic sac and altered Na+/K+ transport.

Age

Viral labyrinthitis is usually observed in adults aged 30-60 years and is rarely observed in children. Meningogenic suppurative labyrinthitis is usually observed in children younger than 2 years, which is the population most at risk for meningitis. Otogenic suppurative labyrinthitis can be observed in persons of any age in the presence of cholesteatoma or as a complication of untreated acute otitis media.7 Serous labyrinthitis is more common in the pediatric age group, in which the vast majority of both acute and chronic otitis media cases are observed.

Clinical

History

A thorough medical history, including symptoms, past medical history, and medications, is essential to diagnosing labyrinthitis as the cause of the patient's vertigo or hearing loss.

  • Symptoms
    • Vertigo (timing and duration, association with movement, head position, and other characteristics)
    • Hearing loss (unilateral or bilateral, mild or profound, duration, and other characteristics)
    • Aural fullness
    • Tinnitus
    • Otorrhea
    • Otalgia
    • Nausea or vomiting
    • Fever
    • Facial weakness or asymmetry
    • Neck pain/stiffness
    • Upper respiratory tract infection symptoms (preceding or concurrent)
    • Visual changes
  • Past medical history
    • Episodes of dizziness or hearing loss
    • Infections
    • Sick contacts
    • Ear surgery
    • Hypertension/hypotension
    • Diabetes
    • Stroke
    • Migraine
    • Trauma (head or cervical spine)
    • Family history of hearing loss or ear disease
  • Medications
    • Aminoglycosides and other ototoxic medications
    • Beta-blockers and other antihypertensives
    • Tranquilizers, including benzodiazepines
    • Antiepileptics
    • Alcohol
    • Illicit drugs

Physical

Include in the physical examination a complete head and neck examination with emphasis on the otologic, ocular, and cranial nerve portions of the examination. A brief neurologic examination is also necessary. Seek the presence of meningeal signs if meningitis is a consideration.

  • Otologic examination
    • Perform an external inspection for signs of mastoiditis, cellulitis, or prior ear surgery.
    • Inspect the ear canal for otitis externa, otorrhea, or vesicles.
    • Inspect the tympanic membrane and middle ear for the presence of perforation, cholesteatoma, middle ear effusion, or acute otitis media.
  • Ocular examination
    • Inspect the ocular range of motion and pupillary response.
    • Perform a funduscopic examination to assess for papilledema.
    • Observe for nystagmus (spontaneous, gaze-evoked, and positional). Perform a Dix-Hallpike test if the patient can tolerate it.
    • If visual changes are suggested, consult an ophthalmologist.
  • Neurologic examination
    • Perform a complete cranial nerve examination.
    • Assess for balance using the Romberg test and tandem gait.
    • Assess cerebellar function by performing finger-to-nose and heel-to-shin tests.

Causes

Little direct evidence suggests a viral cause for labyrinthitis; however, a wealth of epidemiologic evidence implicates a number of viruses as potentially causing inflammation of the labyrinth. Viral labyrinthitis is often preceded by an upper respiratory tract infection and occurs in epidemics. The histologic finding of axonal degeneration in the vestibular nerve suggests a viral etiology for vestibular neuritis.1 The bacteria that cause labyrinthitis are the same bacteria responsible for meningitis and otitis. Gram-negative organisms are found more commonly when cholesteatoma is the inciting factor.

  • Potential viral causes
    • Cytomegalovirus
    • Mumps virus
    • Varicella-zoster virus
    • Rubeola virus
    • Influenza virus
    • Parainfluenza virus
    • Rubella virus
    • Herpes simplex virus 1
    • Adenovirus
    • Coxsackievirus
    • Respiratory syncytial virus
  • Potential bacterial causes
    • S pneumoniae
    • Haemophilus influenzae
    • Moraxella catarrhalis
    • N meningitidis
    • Streptococcus species
    • Staphylococcus species
    • Proteus species
    • Bacteroides species
    • Escherichia coli
    • Mycobacterium tuberculosis

More on Inner Ear, Labyrinthitis

Overview: Inner Ear, Labyrinthitis
Differential Diagnoses & Workup: Inner Ear, Labyrinthitis
Treatment & Medication: Inner Ear, Labyrinthitis
Follow-up: Inner Ear, Labyrinthitis
Multimedia: Inner Ear, Labyrinthitis
References

References

  1. Schuknecht HF, Kitamura K. Second Louis H. Clerf Lecture. Vestibular neuritis. Ann Otol Rhinol Laryngol Suppl. Jan-Feb 1981;90(1 Pt 2):1-19. [Medline].

  2. Kuhweide R, Van de Steene V, Vlaminck S, Casselman JW. Ramsay Hunt syndrome: pathophysiology of cochleovestibular symptoms. J Laryngol Otol. Oct 2002;116(10):844-8. [Medline].

  3. Hato N, Kisaki H, Honda N, Gyo K, Murakami S, Yanagihara N. Ramsay Hunt syndrome in children. Ann Neurol. Aug 2000;48(2):254-6. [Medline].

  4. Schraff SA, Schleiss MR, Brown DK, Meinzen-Derr J, Choi KY, Greinwald JH, et al. Macrophage inflammatory proteins in cytomegalovirus-related inner ear injury. Otolaryngol Head Neck Surg. Oct 2007;137(4):612-8. [Medline].

  5. Gulya AJ. Infections of the labyrinth. In: Bailey BJ, Johnson JT, Pillsbury HC, Tardy ME, Kohut RI, eds. Head and Neck Surgery-Otolaryngology. Vol 2. Philadelphia, Pa: JB Lippincott; 1993:1769-81.

  6. Berlow SJ, Caldarelli DD, Matz GJ, Meyer DH, Harsch GG. Bacterial meningitis and sensorineural hearing loss: a prospective investigation. Laryngoscope. Sep 1980;90(9):1445-52. [Medline].

  7. Jang CH, Park SY, Wang PC. A case of tympanogenic labyrinthitis complicated by acute otitis media. Yonsei Med J. Feb 28 2005;46(1):161-5. [Medline].

  8. Harris JP, Ryan AF. Fundamental immune mechanisms of the brain and inner ear. Otolaryngol Head Neck Surg. Jun 1995;112(6):639-53. [Medline].

  9. Broughton SS, Meyerhoff WE, Cohen SB. Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum. Oct 2004;34(2):544-8. [Medline].

  10. Bovo R, Ciorba A, Martini A. The diagnosis of autoimmune inner ear disease: evidence and critical pitfalls. Eur Arch Otorhinolaryngol. Jan 2009;266(1):37-40. [Medline].

  11. Byl FM. Seventy-six cases of presumed sudden hearing loss occurring in 1973: prognosis and incidence. Laryngoscope. May 1977;87(5 Pt 1):817-25. [Medline].

  12. Baloh RW, Honrubia V, Jacobson K. Benign positional vertigo: clinical and oculographic features in 240 cases. Neurology. Mar 1987;37(3):371-8. [Medline].

  13. Nadol JB Jr. Hearing loss as a sequela of meningitis. Laryngoscope. May 1978;88(5):739-55. [Medline].

  14. Woolley AL, Kirk KA, Neumann AM Jr, McWilliams SM, Murray J, Freind D. Risk factors for hearing loss from meningitis in children: the Children's Hospital experience. Arch Otolaryngol Head Neck Surg. May 1999;125(5):509-14. [Medline].

  15. Bohr V, Paulson OB, Rasmussen N. Pneumococcal meningitis. Late neurologic sequelae and features of prognostic impact. Arch Neurol. Oct 1984;41(10):1045-9. [Medline].

  16. Kutz JW, Simon LM, Chennupati SK, Giannoni CM, Manolidis S. Clinical predictors for hearing loss in children with bacterial meningitis. Arch Otolaryngol Head Neck Surg. Sep 2006;132(9):941-5. [Medline].

  17. Mark AS, Seltzer S, Nelson-Drake J, Chapman JC, Fitzgerald DC, Gulya AJ. Labyrinthine enhancement on gadolinium-enhanced magnetic resonance imaging in sudden deafness and vertigo: correlation with audiologic and electronystagmographic studies. Ann Otol Rhinol Laryngol. Jun 1992;101(6):459-64. [Medline].

  18. Maire R, van Melle G. Diagnostic value of vestibulo-ocular reflex parameters in the detection and characterization of labyrinthine lesions. Otol Neurotol. Jun 2006;27(4):535-41. [Medline].

  19. Strupp M, Zingler VC, Arbusow V, Niklas D, Maag KP, Dieterich M, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med. Jul 22 2004;351(4):354-61. [Medline].

  20. Barkdull GC, Vu C, Keithley EM, Harris JP. Cochlear microperfusion: experimental evaluation of a potential new therapy for severe hearing loss caused by inflammation. Otol Neurotol. Jan 2005;26(1):19-26. [Medline].

  21. Klein M, Koedel U, Pfister HW, Kastenbauer S. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy. Ann Neurol. Oct 2003;54(4):451-8. [Medline].

  22. Wei BP, Mubiru S, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. Jan 25 2006;CD003998. [Medline].

  23. Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol. Jun 2008;29(4):453-60. [Medline].

  24. Plontke SK, Löwenheim H, Mertens J, Engel C, Meisner C, Weidner A, et al. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope. Feb 2009;119(2):359-69. [Medline].

  25. Westerlaken BO, Stokroos RJ, Dhooge IJ, Wit HP, Albers FW. Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol. Nov 2003;112(11):993-1000. [Medline].

  26. Cohen HS, Kimball KT. Decreased ataxia and improved balance after vestibular rehabilitation. Otolaryngol Head Neck Surg. Apr 2004;130(4):418-25. [Medline].

  27. Lee H, Kim HJ, Koo JW, Kim JS. Progression of acute cochleovestibulopathy into anterior inferior cerebellar artery infarction. J Neurol Sci. Mar 15 2009;278(1-2):119-22. [Medline].

Further Reading

Keywords

labyrinthitis of the inner ear, labyrinthitis, viral labyrinthitis, serous labyrinthitis, bacterial labyrinthitis, suppurative labyrinthitis, sudden sensorineural hearing loss, neurolabyrinthitis, vestibulocochleitis, vestibulocochlearis, sudden hearing loss, ear infection, inner ear infection, ear labyrinth infection, hearing disorder, hearing disturbance, balance disorder, balance disturbance, vertigo, dysequilibrium, hearing loss, vestibular neuritis, herpes zoster oticus, Ramsay-Hunt syndrome, varicella-zoster virus, varicella reactivation, zoster reactivation, rubella, cytomegalovirus, CMV, mumps, measles, SNHL, herpes oticus, labyrinthine inflammation, labyrinthine disease, labyrinthine disorder, labyrinthine infection

Contributor Information and Disclosures

Author

Mark E Boston, MD, Chairman, Department of Otolaryngology-Head and Neck Surgery, Wilford Hall Medical Center, Lackland Air Force Base
Mark E Boston, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, and American Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Barry Strasnick, MD, FACS, Chairman, Professor, Department of Otolaryngology - Head and Neck Surgery, Eastern Virginia Medical School
Barry Strasnick, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American College of Surgeons, American Medical Association, American Tinnitus Association, Ear Foundation Alumni Society, Norfolk Academy of Medicine, North American Skull Base Society, Society of University Otolaryngologists-Head and Neck Surgeons, Vestibular Disorders Association, and Virginia Society of Otolaryngology-Head and Neck Surgery
Disclosure: Nothing to disclose.

Amalia Renee Steinberg, MD, Resident Physician, Department of Otolaryngology, Eastern Virginia Medical School
Amalia Renee Steinberg, MD is a member of the following medical societies: Alpha Omega Alpha
Disclosure: Nothing to disclose.

Medical Editor

Michael E Hoffer, MD, Director, Spatial Orientation Center, Department of Otolaryngology, Naval Medical Center of San Diego
Michael E Hoffer, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery
Disclosure: American biloogical group Royalty Other

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Gerard J Gianoli, MD, Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine; Vice President, The Ear and Balance Institute; Chief Executive Officer, Ponchartrain Surgery Center
Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society
Disclosure: Vesticon, Inc. None Board membership

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Robert A Egan, MD, Director of Neuro-Ophthalmology, St Helena Hospital
Robert A Egan, MD is a member of the following medical societies: American Academy of Neurology, American Heart Association, North American Neuro-Ophthalmology Society, and Oregon Medical Association
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.